PRE Prenetics: Market Capitalization to Book Value Ratio

Official company branding of Prenetics (PRE)

This daily price chart for Prenetics Global (PRE) illustrates the quotes for the preventive diagnostics provider, where the indicator stands at 3.33. The business relies on robotic DNA sequencing, which minimizes costs as volumes scale. Growth is driven by the Asian market and the integration of CircleDNA into insurance. A flawless image as an innovator in cancer screening ensures high user confidence in the accuracy of the tests.

prenetics.com (PRE): Capitalization to Book Value Ratio from 04/28/2023 to 10/27/2026

PRE (Prenetics Global): analytical breakdowns and indicator data

- price and consensus price forecast:
Price Chart prenetics.com|PRE - Consensus Target
- market capitalization data:
Market Capitalization Prenetics Global Ltd|PRE - Total Enterprise Value
- book capitalization data:
Book Value per Share Prenetics|PRE - Accounting Capitalization|Market Capitalization to Book Value Ratio prenetics.com|PRE - Company Total Assets
- debt and liquidity data:
Debt to Equity Prenetics Global|PRE - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital prenetics.com|PRE - Company Aggregate Debts|Debt to Book Capitalization Ratio Prenetics Global Ltd
Fundamental valuation:Prenetics Global
Core merchandise of Prenetics Global

This ratio compares the market value of shares with net assets, determining the premium or discount to real capital and the market's level of confidence in asset quality. By analyzing the P/BV chart for Prenetics Global (PRE), an investor can assess the impact of reporting digitalization and environmental responsibility on capitalization, identifying hidden value degradation or the resilience of the business model.

Main competitors

A (Agilent Technologies) - Market Value to Book Value Ratio|questdiagnostics.com (DGX) - Market Cap to Net Assets Ratio|Market Capitalization to Book Value Ratio ILMN (Illumina)|Market-to-Book Ratio Exact Sciences Corp|Market Capitalization to Book Value Ratio PerkinElmer RVTY|Capitalization to Book Value Ratio Bio-Rad Corp (BIO)|Market Capitalization to Book Value Ratio NNNN (Anbio Biotechnology)|soterahealth.com - Market Capitalization to Book Value Ratio|QuidelOrtho Corporation (QDEL) - Market Value to Book Value Ratio|OPK - Capitalization to Book Value Ratio|CDNA: Market Capitalization to Book Value Ratio|MRVI (Maravai) - Market Capitalization to Book Value Ratio|Market Value to Book Value Ratio Fulgent Genetics, Inc.|Market Value to Book Value Ratio fluidigm.com (LAB)|Cytek Biosciences - Market Cap to Net Assets Ratio|Market-to-Book Ratio OSUR (OraSure Technologies, Inc.)|Market Value to Book Value Ratio XGN|Market Capitalization to Book Value MDxHealth, Inc. MDXH|Market Capitalization to Book Value Ratio LUCD (Lucid Diagnostics Inc.)|IMDX: Market Capitalization to Book Value|trinitybiotech.com - Market Value to Book Value Ratio|PRPH (ProPhase Labs Inc) - Market Capitalization to Book Value|Market Value to Book Value Ratio Ainos Corp AIMD|Market Capitalization to Net Assets CODX|Heart Test Laboratories (HSCS) - Market Value to Book Value Ratio|Market Value to Book Value biomerica.com (BMRA)|CDIO: Market Capitalization to Book Value Ratio|Virax Biolabs Group Limited - Market-to-Book Ratio|Bluejay (BJDX) - Market Value to Book Value Ratio|AWH - Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio AXDX|Market-to-Book Ratio CENTOGENE|Enzo Biochem Inc. (ENZ) - Market Cap to Net Assets Ratio|Market Cap to Book Value Multiple Fresh2|GENE (Genetic Technologies) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value 23andMe Inc (ME)|Psychemedics - Market Capitalization to Book Value Ratio